Dr. Michael Tuscan focuses on the development, execution and enforcement of worldwide market exclusivity strategies for products and technologies that are the core assets of biotechnology companies of all sizes.

Download full bio 


  • Sixth Street Invests in Blueprint Medicines 

  • Forbius Agrees to Sell to Bristol Myers Squibb 

  • Iconic Therapeutics Series C Financing 

  • FibroGen Closes Largest Biotech IPO in 12 Years 

  • T2 Biosystems IPO 

  • View all


  • Georgetown University Law Center
    JD, 1998

  • Emory University
    PhD, Molecular Biology

  • Illinois State University
    MS, Genetics

  • Carroll College
    BS, 1984

Admissions & Credentials

District of Columbia


U.S. Patent and Trademark Office

Rankings & Accolades

    Best Lawyers in America: Technology Law

    Best Lawyers: Leading IP Lawyer

    IAM Patent 1000: Top Patent Lawyer

    Legal 500: Top Lawyer for Life Sciences and Patent Prosecution

    Managing Intellectual Property: IP Star

    Who's Who Legal: Top Patent Lawyer